Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Correction: Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.

Lucas ED, Finlon JM, Burchill MA, McCarthy MK, Morrison TE, Colpitts TM, Tamburini BAJ.

J Immunol. 2019 Dec 20. pii: ji1901400. doi: 10.4049/jimmunol.1901400. [Epub ahead of print] No abstract available.

PMID:
31862709
2.

Chikungunya virus replication in skeletal muscle cells is required for disease development.

Lentscher AJ, McCarthy MK, May NA, Davenport BJ, Montgomery SA, Raghunathan K, McAllister N, Silva LA, Morrison TE, Dermody TS.

J Clin Invest. 2019 Dec 3. pii: 129893. doi: 10.1172/JCI129893. [Epub ahead of print]

3.

Vaccine-Induced Skewing of T Cell Responses Protects Against Chikungunya Virus Disease.

Broeckel RM, Haese N, Ando T, Dmitriev I, Kreklywich CN, Powers J, Denton M, Smith P, Morrison TE, Heise M, DeFilippis V, Messaoudi I, Curiel DT, Streblow DN.

Front Immunol. 2019 Oct 31;10:2563. doi: 10.3389/fimmu.2019.02563. eCollection 2019.

4.

dsRNA-Seq: Identification of Viral Infection by Purifying and Sequencing dsRNA.

Decker CJ, Steiner HR, Hoon-Hanks LL, Morrison JH, Haist KC, Stabell AC, Poeschla EM, Morrison TE, Stenglein MD, Sawyer SL, Parker R.

Viruses. 2019 Oct 14;11(10). pii: E943. doi: 10.3390/v11100943.

5.

Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses.

Carpentier KS, Davenport BJ, Haist KC, McCarthy MK, May NA, Robison A, Ruckert C, Ebel GD, Morrison TE.

Elife. 2019 Oct 9;8. pii: e49163. doi: 10.7554/eLife.49163.

6.

Clearance of Chikungunya Virus Infection in Lymphoid Tissues Is Promoted by Treatment with an Agonistic Anti-CD137 Antibody.

Hong JP, McCarthy MK, Davenport BJ, Morrison TE, Diamond MS.

J Virol. 2019 Nov 26;93(24). pii: e01231-19. doi: 10.1128/JVI.01231-19. Print 2019 Dec 15.

PMID:
31578287
7.

Studies on Dibenzylamines as Inhibitors of Venezuelan Equine Encephalitis Virus.

Nguyen TH, Haese NN, Madadi N, Sarkar S, Bonin K, Streblow CE, Taft-Benz S, Tower NA, Rasmussen L, Bostwick R, Augelli-Szafran CE, Suto MJ, Morrison TE, DeFilippis V, Heise MT, Streblow DN, Pathak AK.

ACS Infect Dis. 2019 Dec 13;5(12):2014-2028. doi: 10.1021/acsinfecdis.9b00035. Epub 2019 Jul 11.

PMID:
31257853
8.

Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.

Broeckel R, Sarkar S, May NA, Totonchy J, Kreklywich CN, Smith P, Graves L, DeFilippis VR, Heise MT, Morrison TE, Moorman N, Streblow DN.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02325-18. doi: 10.1128/AAC.02325-18. Print 2019 Apr.

9.

The Clinical Features, Pathogenesis and Methotrexate Therapy of Chronic Chikungunya Arthritis.

Amaral JK, Taylor PC, Teixeira MM, Morrison TET, Schoen RT.

Viruses. 2019 Mar 22;11(3). pii: E289. doi: 10.3390/v11030289. Review.

10.

Chronic Chikungunya Virus Disease.

McCarthy MK, Davenport BJJ, Morrison TE.

Curr Top Microbiol Immunol. 2019 Jan 18. doi: 10.1007/82_2018_147. [Epub ahead of print]

PMID:
30656438
11.

SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice.

Davenport BJ, Martin CG, Beverley SM, Orlicky DJ, Vazquez-Torres A, Morrison TE.

PLoS Negl Trop Dis. 2018 Oct 29;12(10):e0006921. doi: 10.1371/journal.pntd.0006921. eCollection 2018 Oct.

12.

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

Gralinski LE, Sheahan TP, Morrison TE, Menachery VD, Jensen K, Leist SR, Whitmore A, Heise MT, Baric RS.

mBio. 2018 Oct 9;9(5). pii: e01753-18. doi: 10.1128/mBio.01753-18.

13.

Blocking the Exit: CHIKV Neutralizing Antibodies Nip Viral Egress in the Bud.

McCarthy MK, Morrison TE.

Cell Host Microbe. 2018 Sep 12;24(3):328-330. doi: 10.1016/j.chom.2018.08.008.

14.

Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response.

Lucas ED, Finlon JM, Burchill MA, McCarthy MK, Morrison TE, Colpitts TM, Tamburini BAJ.

J Immunol. 2018 Sep 15;201(6):1735-1747. doi: 10.4049/jimmunol.1800271. Epub 2018 Jul 25. Erratum in: J Immunol. 2019 Dec 20;:.

15.

Chikungunya virus impairs draining lymph node function by inhibiting HEV-mediated lymphocyte recruitment.

McCarthy MK, Davenport BJ, Reynoso GV, Lucas ED, May NA, Elmore SA, Tamburini BA, Hickman HD, Morrison TE.

JCI Insight. 2018 Jul 12;3(13). pii: 121100. doi: 10.1172/jci.insight.121100.

16.

Ross River virus envelope glycans contribute to disease through activation of the host complement system.

Gunn BM, Jones JE, Shabman RS, Whitmore AC, Sarkar S, Blevins LK, Morrison TE, Heise MT.

Virology. 2018 Feb;515:250-260. doi: 10.1016/j.virol.2017.12.022. Epub 2018 Jan 8.

17.

Inflammatory monocytes mediate control of acute alphavirus infection in mice.

Haist KC, Burrack KS, Davenport BJ, Morrison TE.

PLoS Pathog. 2017 Dec 15;13(12):e1006748. doi: 10.1371/journal.ppat.1006748. eCollection 2017 Dec.

18.

Innate immune control of alphavirus infection.

Carpentier KS, Morrison TE.

Curr Opin Virol. 2018 Feb;28:53-60. doi: 10.1016/j.coviro.2017.11.006. Epub 2017 Nov 22. Review.

19.

Mutations in the E2 Glycoprotein and the 3' Untranslated Region Enhance Chikungunya Virus Virulence in Mice.

Hawman DW, Carpentier KS, Fox JM, May NA, Sanders W, Montgomery SA, Moorman NJ, Diamond MS, Morrison TE.

J Virol. 2017 Sep 27;91(20). pii: e00816-17. doi: 10.1128/JVI.00816-17. Print 2017 Oct 15.

20.

Identification of Interactions between Sindbis Virus Capsid Protein and Cytoplasmic vRNA as Novel Virulence Determinants.

Sokoloski KJ, Nease LM, May NA, Gebhart NN, Jones CE, Morrison TE, Hardy RW.

PLoS Pathog. 2017 Jun 29;13(6):e1006473. doi: 10.1371/journal.ppat.1006473. eCollection 2017 Jun.

21.

Persistent RNA virus infections: do PAMPS drive chronic disease?

McCarthy MK, Morrison TE.

Curr Opin Virol. 2017 Apr;23:8-15. doi: 10.1016/j.coviro.2017.01.003. Epub 2017 Feb 17. Review.

22.

Animal Models of Zika Virus Infection, Pathogenesis, and Immunity.

Morrison TE, Diamond MS.

J Virol. 2017 Mar 29;91(8). pii: e00009-17. doi: 10.1128/JVI.00009-17. Print 2017 Apr 15. Review.

23.

Animal Models of Chikungunya Virus Infection and Disease.

Haese NN, Broeckel RM, Hawman DW, Heise MT, Morrison TE, Streblow DN.

J Infect Dis. 2016 Dec 15;214(suppl 5):S482-S487. Review.

24.

4EBP-Dependent Signaling Supports West Nile Virus Growth and Protein Expression.

Shives KD, Massey AR, May NA, Morrison TE, Beckham JD.

Viruses. 2016 Oct 18;8(10). pii: E287.

25.

Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence.

Hawman DW, Fox JM, Ashbrook AW, May NA, Schroeder KMS, Torres RM, Crowe JE Jr, Dermody TS, Diamond MS, Morrison TE.

Cell Rep. 2016 Aug 2;16(5):1326-1338. doi: 10.1016/j.celrep.2016.06.076. Epub 2016 Jul 21.

26.

Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.

Ashbrook AW, Lentscher AJ, Zamora PF, Silva LA, May NA, Bauer JA, Morrison TE, Dermody TS.

mBio. 2016 May 24;7(3). pii: e00693-16. doi: 10.1128/mBio.00693-16.

27.

Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms?

McCarthy MK, Morrison TE.

Future Microbiol. 2016;11(3):331-4. doi: 10.2217/fmb.15.147. Epub 2016 Mar 4. No abstract available.

28.

Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain.

Beatman EL, Massey A, Shives KD, Burrack KS, Chamanian M, Morrison TE, Beckham JD.

J Virol. 2015 Dec 30;90(6):2767-82. doi: 10.1128/JVI.02949-15.

29.

Helminth-induced arginase-1 exacerbates lung inflammation and disease severity in tuberculosis.

Monin L, Griffiths KL, Lam WY, Gopal R, Kang DD, Ahmed M, Rajamanickam A, Cruz-Lagunas A, Zúñiga J, Babu S, Kolls JK, Mitreva M, Rosa BA, Ramos-Payan R, Morrison TE, Murray PJ, Rangel-Moreno J, Pearce EJ, Khader SA.

J Clin Invest. 2015 Dec;125(12):4699-713. doi: 10.1172/JCI77378. Epub 2015 Nov 16.

30.

Myeloid Cell Arg1 Inhibits Control of Arthritogenic Alphavirus Infection by Suppressing Antiviral T Cells.

Burrack KS, Tan JJ, McCarthy MK, Her Z, Berger JN, Ng LF, Morrison TE.

PLoS Pathog. 2015 Oct 5;11(10):e1005191. doi: 10.1371/journal.ppat.1005191. eCollection 2015 Oct.

31.

The Global Virus Network: Challenging chikungunya.

McSweegan E, Weaver SC, Lecuit M, Frieman M, Morrison TE, Hrynkow S.

Antiviral Res. 2015 Aug;120:147-52. doi: 10.1016/j.antiviral.2015.06.003. Epub 2015 Jun 10. Review.

32.

Noncapped Alphavirus Genomic RNAs and Their Role during Infection.

Sokoloski KJ, Haist KC, Morrison TE, Mukhopadhyay S, Hardy RW.

J Virol. 2015 Jun;89(11):6080-92. doi: 10.1128/JVI.00553-15. Epub 2015 Apr 1.

33.

Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.

Halemano K, Barrett BS, Heilman KJ, Morrison TE, Santiago ML.

J Virol. 2015 Apr;89(7):4011-4. doi: 10.1128/JVI.03399-14. Epub 2015 Jan 14.

34.

CD8+ T cells control Ross River virus infection in musculoskeletal tissues of infected mice.

Burrack KS, Montgomery SA, Homann D, Morrison TE.

J Immunol. 2015 Jan 15;194(2):678-89. doi: 10.4049/jimmunol.1401833. Epub 2014 Dec 8.

35.

The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases.

Burrack KS, Morrison TE.

Front Immunol. 2014 Sep 8;5:428. doi: 10.3389/fimmu.2014.00428. eCollection 2014. Review.

36.

Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.

Ashbrook AW, Burrack KS, Silva LA, Montgomery SA, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Nov;88(21):12180-92. doi: 10.1128/JVI.01672-14. Epub 2014 Aug 20.

37.

Reemergence of chikungunya virus.

Morrison TE.

J Virol. 2014 Oct;88(20):11644-7. doi: 10.1128/JVI.01432-14. Epub 2014 Jul 30. Review.

38.

Essential role for the lectin pathway in collagen antibody-induced arthritis revealed through use of adenovirus programming complement inhibitor MAp44 expression.

Banda NK, Mehta G, Kjaer TR, Takahashi M, Schaack J, Morrison TE, Thiel S, Arend WP, Holers VM.

J Immunol. 2014 Sep 1;193(5):2455-68. doi: 10.4049/jimmunol.1400752. Epub 2014 Jul 28.

39.

Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes.

Pal P, Fox JM, Hawman DW, Huang YJ, Messaoudi I, Kreklywich C, Denton M, Legasse AW, Smith PP, Johnson S, Axthelm MK, Vanlandingham DL, Streblow DN, Higgs S, Morrison TE, Diamond MS.

J Virol. 2014 Aug;88(15):8213-26. doi: 10.1128/JVI.01032-14. Epub 2014 May 14.

40.

Attenuating mutations in nsP1 reveal tissue-specific mechanisms for control of Ross River virus infection.

Stoermer Burrack KA, Hawman DW, Jupille HJ, Oko L, Minor M, Shives KD, Gunn BM, Long KM, Morrison TE.

J Virol. 2014 Apr;88(7):3719-32. doi: 10.1128/JVI.02609-13. Epub 2014 Jan 15.

41.

A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.

Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, Dermody TS.

J Virol. 2014 Mar;88(5):2385-97. doi: 10.1128/JVI.03116-13. Epub 2013 Dec 26.

42.

Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response.

Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE.

J Virol. 2013 Dec;87(24):13878-88. doi: 10.1128/JVI.02666-13. Epub 2013 Oct 16.

43.

Large spontaneous pneumothorax with relatively minor symptoms.

Morrison TE.

BMJ Case Rep. 2013 May 8;2013. pii: bcr2013009531. doi: 10.1136/bcr-2013-009531. No abstract available.

44.

A tyrosine-to-histidine switch at position 18 of the Ross River virus E2 glycoprotein is a determinant of virus fitness in disparate hosts.

Jupille HJ, Medina-Rivera M, Hawman DW, Oko L, Morrison TE.

J Virol. 2013 May;87(10):5970-84. doi: 10.1128/JVI.03326-12. Epub 2013 Mar 20.

45.

Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.

Stoermer KA, Burrack A, Oko L, Montgomery SA, Borst LB, Gill RG, Morrison TE.

J Immunol. 2012 Oct 15;189(8):4047-59. doi: 10.4049/jimmunol.1201240. Epub 2012 Sep 12.

46.

Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm.

Dickson AM, Anderson JR, Barnhart MD, Sokoloski KJ, Oko L, Opyrchal M, Galanis E, Wilusz CJ, Morrison TE, Wilusz J.

J Biol Chem. 2012 Oct 19;287(43):36229-38. doi: 10.1074/jbc.M112.371203. Epub 2012 Aug 22.

47.

Mannose binding lectin is required for alphavirus-induced arthritis/myositis.

Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT.

PLoS Pathog. 2012;8(3):e1002586. doi: 10.1371/journal.ppat.1002586. Epub 2012 Mar 22.

48.

The relationship between prenatal control, expectations, experienced control, and birth satisfaction among primiparous women.

Fair CD, Morrison TE.

Midwifery. 2012 Feb;28(1):39-44. doi: 10.1016/j.midw.2010.10.013. Epub 2011 Apr 1.

PMID:
21458895
49.

A protective role for complement C3 protein during pandemic 2009 H1N1 and H5N1 influenza A virus infection.

O'Brien KB, Morrison TE, Dundore DY, Heise MT, Schultz-Cherry S.

PLoS One. 2011 Mar 9;6(3):e17377. doi: 10.1371/journal.pone.0017377.

50.

Complement and viral pathogenesis.

Stoermer KA, Morrison TE.

Virology. 2011 Mar 15;411(2):362-73. doi: 10.1016/j.virol.2010.12.045. Epub 2011 Feb 2. Review.

Supplemental Content

Loading ...
Support Center